TECNOLOGÍA PARA LA MONITORIZACIÓN Y CONTROL DE LA DIABETES

VolverVolver

Resultados 72 resultados LastUpdate Última actualización 01/02/2023 [12:31:00] pdf PDF xls XLS

Solicitudes publicadas en los últimos 60 días / Applications published in the last 60 days



Página1 de 3 nextPage   por página


TRANSPORT ELEMENT FOR TRANSPORTING A SUBSTANCE CONTAINED IN A RESERVOIR, INFUSION SET AND GLUCOSE REGULATING SYSTEM COMPRISING THE FORMER AND METHOD OF CONNECTING SUCH A TRANSPORT ELEMENT TO A RESERVOIR

NºPublicación: WO2023001789A1 26/01/2023

Solicitante:

INREDA DIABETIC B V [NL]

Resumen de: WO2023001789A1

The invention relates to a transport element for transporting a substance contained in a reservoir comprising a transport means, such as a conduit, tube, hose or the like, and a connector arranged at an inlet end of the transport means for connecting to said reservoir such that in a connected condition in which the connector is connected to said reservoir a medium through flow connection is provided between said reservoir and the inlet end of the transport means for receiving said substance from said reservoir, wherein the connector comprises aligning and holding means for aligning and holding the reservoir in a predetermined orientation with respect to and/or position along a longitudinal axis of the connector. The invention also relates to an infusion set, system or combination comprising such transport element, and to a method of at least fluidly connecting such a transport element to a reservoir.

traducir

SYSTEMS AND APPARATUSES FOR PROTECTING CONTINUOUS GLUCOSE MONITORING AND INSULIN INFUSION DEVICES

NºPublicación: WO2023003673A1 26/01/2023

Solicitante:

FREEDOM BAND LLC [US]

Resumen de: WO2023003673A1

Systems and apparatuses for securing and protecting diabetes management devices, such as continuous glucose monitoring (CGM) devices and insulin infusion sets. An apparatus (10) comprises a base (20) having multiple pairs of arms which can be attached to a band. The apparatus (10) also comprises a shell (30) for retaining a diabetes management device and which may be unitarily formed with, or removably attached to, the base (20). A system may include an apparatus (510), a diabetes management device (501) retained in the shell (530) of the apparatus (510), and a band (540) attached to the base (530) of the apparatus (510). The band (540) may be placed around a body part of a user, such as an arm or the abdomen. A system can include an adhesive patch (750) having an adhesive layer overlaid with multiple liners (753A, 753B, 753C, 753D) having cutlines (755A, 755B, 755C, 755D) formed therebetween.

traducir

Use of Glucose Control Indicators for Risk Assessment and Treatment of Neurodevelopmental Disorders and Techniques for Establishing the Status of Chronic Glucose Control

NºPublicación: US2023022094A1 26/01/2023

Solicitante:

MOVSAS TAMMY [US]

CA_3163798_PA

Resumen de: US2023022094A1

Dysglycemia as a risk factor for neurodevelopmental disorder or developmental diabetes. The risk is assessed based on measurement of a glucose control indicator in a blood sample. One particular example of a neurodevelopmental disorder is retinopathy of prematurity in an infant. One particular example of a glucose control indicator is ‘comprehensive glycated hemoglobin fraction’ or ‘comprehensive glycated albumin fraction.’ This is calculated using ‘total whole blood protein’ in the denominator. In the case of chronic hyperglycemia, there is an increased risk of proliferative retinopathy of prematurity. In the case of chronic hypoglycemia, there is an increased risk of non-proliferative retinopathy of prematurity. This ‘total whole blood protein’ technique could also be used to determine the glucose control status in other types of patients.

traducir

FLOWRATE CONTROL FOR SELF-PRESSURIZED RESERVOIR OF A DEVICE FOR DELIVERING MEDICATION

NºPublicación: US2023029043A1 26/01/2023

Solicitante:

AITA BIO INC [US]

WO_2021119101_A1

Resumen de: US2023029043A1

A device is disclosed that is configured as a fully autonomous and integrated wearable apparatus for diabetes management. The device comprise a self-pressurized reservoir for storing the medication for subsequent delivery to a patient, a needle for delivering the medication to the patient subcutaneously, a first MEMS device configured as a microvalve in a fluid path between the self-pressurized reservoir and needle for controlling flowrate of medication through the needle as the self-pressurized reservoir discharges, a second MEMS device configured as a micropump configured to increase flowrate of the medication in the fluid path to ensure a constant flowrate in the fluid path as the self-pressurized discharges independent of orientation of the device, a flow sensor configured to measure flowrate in the fluid path for controlling microvalve and micropump, and control circuitry connected to the microvalve, micropump and flow sensor for controlling operation of the micropump and microvalve.

traducir

Silicone Hydrogel Based Fluorescent Assay and Contact Lens

NºPublicación: US2023025694A1 26/01/2023

Solicitante:

UNIV MARYLAND [US]

Resumen de: US2023025694A1

A material, article, system and method include a probe composition that includes a hydrophobic portion, a hydrophilic portion, an analyte-binding portion and a fluorophore portion. The analyte-binding portion is configured to bind to an analyte in an aqueous solution. The fluorophore portion is configured to change an optical property of fluorescent light emitted in response to incident excitation light when the probe composition changes between a first state in which the analyte is not bound to the analyte-binding portion and a second state in which the analyte binds to the analyte-binding portion. A material includes the probe composition and a silicone hydrogel substrate having a hydrogel network that allows flow of aqueous solution through the solution and a silicone network that occupies interstices of the hydrogel network. A contact lens having the material enables remote detection of glucose concentration in tear fluid of a subject.

traducir

SYSTEMS AND METHODS FOR BIOSENSOR CROSS-CALIBRATION

NºPublicación: US2023027609A1 26/01/2023

Solicitante:

WAVEFORM TECH INC [US]

CN_114126477_PA

Resumen de: US2023027609A1

Embodiments provide for methods, systems, apparatus and computer readable media for calibrating an analyte sensor upon insertion into tissue of a subject based at least in part on parameters obtained from another analyte sensor already calibrated and previously inserted into the tissue of the subject. As an example, a method may include predicting a background current associated with the newly inserted sensor, subtracting the background current from a current measured by the newly inserted sensor, and converting the subtracted current to a glucose value, the converting based at least in part on the parameters obtained from the previously inserted analyte sensor. In this way, the newly inserted sensor may be calibrated without relying on actual blood-based analyte measurements, and accuracy and sensitivity of the newly inserted sensor may be improved.

traducir

METHODS, DEVICES, AND SYSTEMS FOR PHYSIOLOGICAL PARAMETER ANALYSIS

NºPublicación: US2023024262A1 26/01/2023

Solicitante:

ABBOTT DIABETES CARE INC [US]

US_2018235524_PA

Resumen de: US2023024262A1

Methods, devices, and systems may use a kinetic model to determine physiological parameters related to the kinetics of red blood cell glycation, elimination, and generation. Such physiological parameters can be used, for example, to determine a more reliable calculated HbA1c. In another example, a method may comprise: receiving a plurality of glucose levels over a time period; receiving a glycated hemoglobin (HbA1c) level corresponding to an end of the time period; determining at least one physiological parameter selected from the group consisting of: a red blood cell glycation rate constant (kgly), a red blood cell generation rate constant (kgen), a red blood cell elimination constant (kage), and an apparent glycation constant (K), based on (1) the plurality of glucose levels and (2) the HbA1c level; and adjusting a glucose level target based on the at least one physiological parameter.

traducir

SYSTEMS AND METHODS FOR TECHNICAL SUPPORT OF CONTINUOUS ANALYTE MONITORING AND SENSOR SYSTEMS

NºPublicación: US2023027200A1 26/01/2023

Solicitante:

DEXCOM INC [US]

US_2021398662_A1

Resumen de: US2023027200A1

Disclosed are systems and methods for providing automated or semi-automated technical support for patients using medical devices, such as continuous glucose monitoring systems. Disclosed embodiments of automated tech support system include collection and storage of copies of streams of medical device data on multiple servers, analysis and comparison of data streams, remote tech support initiation and usage of the automated tech support system for providing improved products and services by storing and analyzing historical tech support data.

traducir

SYSTEMS AND APPARATUSES FOR PROTECTING CONTINUOUS GLUCOSE MONITORING AND INSULIN INFUSION DEVICES

NºPublicación: US2023026387A1 26/01/2023

Solicitante:

FREEDOM BAND LLC [US]

WO_2023003673_PA

Resumen de: US2023026387A1

Systems and apparatuses for securing and protecting diabetes management devices, such as continuous glucose monitoring (CGM) devices and insulin infusion sets. An apparatus comprises a base having multiple pairs of arms which can be attached to a band. The apparatus also comprises a shell for retaining a diabetes management device and which may be unitarily formed with, or removably attached to, the base. A system may include an apparatus, a diabetes management device retained in the shell of the apparatus, and a band attached to the base of the apparatus. The band may be placed around a body part of a user, such as an arm or the abdomen. A system can include an adhesive patch which can adhere to the shell of an apparatus and which has an adhesive layer overlaid with multiple liners having cutlines formed therebetween.

traducir

METHODS, DEVICES, AND SYSTEMS FOR PHYSIOLOGICAL PARAMETER ANALYSIS

NºPublicación: US2023027904A1 26/01/2023

Solicitante:

ABBOTT DIABETES CARE INC [US]

CN_115004310_A

Resumen de: US2023027904A1

A method for deriving physiological parameters may include: measuring a glucose level of a subject over time; measuring a HbA1c of individual red blood cells in a sample comprising a plurality of red blood cells; deriving a measured cellular HbA1c distribution of the sample; and calculating at least one physiological parameter selected from the group consisting of (a) a red blood cell elimination constant (kage), (b) a red blood cell glycation rate constant (kgly), and/or (c) an apparent glycation constant (K) based on the measured cellular HbA1c distribution and the glucose levels of the subject over time.

traducir

SYSTEM AND METHOD FOR PROVIDING ALERTS OPTIMIZED FOR A USER

NºPublicación: US2023013632A1 19/01/2023

Solicitante:

DEXCOM INC [US]

AU_2022256146_A1

Resumen de: US2023013632A1

Systems and methods are disclosed that provide smart alerts to users, e.g., alerts to users about diabetic states that are only provided when it makes sense to do so, e.g., when the system can predict or estimate that the user is not already cognitively aware of their current condition, e.g., particularly where the current condition is a diabetic state warranting attention. In this way, the alert or alarm is personalized and made particularly effective for that user. Such systems and methods still alert the user when action is necessary, e.g., a bolus or temporary basal rate change, or provide a response to a missed bolus or a need for correction, but do not alert when action is unnecessary, e.g., if the user is already estimated or predicted to be cognitively aware of the diabetic state warranting attention, or if corrective action was already taken.

traducir

CANNULA INSERTION DETECTION

NºPublicación: US2023016823A1 19/01/2023

Solicitante:

BECTON DICKINSON CO [US]

ES_2886214_T3

Resumen de: US2023016823A1

Sensors are disclosed that detect whether a cannula is properly inserted to its full depth in a subject's skin. The sensors may be used with a blood glucose monitor, or with a continuous insulin infusion pump, infusion set, or other system involving intermittent or continuous testing and/or drug delivery.

traducir

INFUSION SYSTEM WITH CONCURRENT TPN/INSULIN INFUSION

NºPublicación: US2023017117A1 19/01/2023

Solicitante:

ICU MEDICAL INC [US]

AU_2015364478_A1

Resumen de: US2023017117A1

An infusion system to provide concurrent TPN/insulin infusion including: a fluid administration set having a primary line in fluid communication with the TPN source, a secondary line in fluid communication with the insulin source, and a common outlet line; a pump operable to removably receive the fluid administration set, the pump being operable to concurrently move the TPN solution through the primary line in response to a TPN solution flow rate signal and the insulin solution through the secondary line in response to an insulin solution flow rate signal; and a flow controller operable to provide the TPN solution flow rate signal and the insulin solution flow rate signal to the pump. The flow controller is further operable to vary the TPN solution flow rate signal and the insulin solution flow rate signal to vary a ratio of TPN solution to insulin solution provided to the common outlet line.

traducir

SENSOR SYSTEMS, DEVICES, AND METHODS FOR CONTINUOUS GLUCOSE MONITORING

NºPublicación: US2023017510A1 19/01/2023

Solicitante:

MEDTRONIC MINIMED INC [US]

US_2019246960_A1

Resumen de: US2023017510A1

Electrochemical impedance spectroscopy (EIS) may be used in conjunction with continuous glucose monitoring (CGM) to enable identification of valid and reliable sensor data, as well implementation of Smart Calibration algorithms.

traducir

METHOD FOR MODIFICATION OF INSULIN DELIVERY DURING PREGNANCY IN AUTOMATIC INSULIN DELIVERY SYSTEMS

NºPublicación: US2023018355A1 19/01/2023

Solicitante:

INSULET CORP [US]

EP_4120281_PA

Resumen de: US2023018355A1

The disclosed embodiments are directed to methods for dynamically adjusting the total daily insulin requirements of a user during pregnancy, based on the gestational week. An initial estimate of the adjusted total daily insulin requirement may be calculated as a multiple of the pre-pregnancy total daily insulin requirement, based on an average scale factor from a population of pregnant women suffering from Type I diabetes mellitus. An automatic drug delivery device may adjust the initial estimate of the total daily insulin requirement based on blood glucose level readings from a continuous glucose monitor during the course of the pregnancy.

traducir

Apparatus to detect salt concentrations and glucose in bodily fluids

NºPublicación: US11553861B1 17/01/2023

Solicitante:

MY SALT AND SUGAR LLC [US]

Resumen de: US11553861B1

The present development is a method and device to monitor the salt level in a patient's blood without the need of laboratory facilities or intervention by medical personnel. The basic device is designed to measure the concentration of analytes, specifically sodium ion and potassium ion, in the patient's blood and to communicate the analyte level to the patient essentially instantaneously through a mobile monitor or display screen. In a variation, the device combines the analyte-concentration measuring function with a means for measuring the concentration of glucose in blood, and the blood analyte level and glucose level are displayed to the patient essentially instantaneously. Both the salt level device and the salt level+glucose level device may be further adapted to allow for the salt and glucose level data to be stored in a data storage base so the patient has an historical record of the concentration levels.

traducir

NON-INVASIVE BLOOD GLUCOSE DETECTOR AND DETECTION METHOD

NºPublicación: WO2023280017A1 12/01/2023

Solicitante:

WUXI KHOOO MEDICAL TECH CO LTD [CN]

CN_113261954_A

Resumen de: WO2023280017A1

A non-invasive blood glucose meter comprises a housing (1), a controller (2), a power supply module (3), cooling fins (4), a power switch (5), an LED light source (6), and a spectral sensor (7). A finger compartment (8) is provided in the housing (1); the power supply module (3) and the controller (2) are electrically connected to each other and are disposed in the housing (1); the LED light source (6) is disposed at the end of the finger compartment (8) and is located on the top surface of the finger compartment (8); the cooling fins (4) are connected to the spectral sensor (7); the spectral sensor (7) is located at the end of the finger compartment (8) and located on the bottom surface of the finger compartment (8); the LED light source (6) and the spectral sensor (7) are located on a same straight line. During non-invasive blood glucose detection, position limit, classification and recognition, detection position determining, and fingertip pressing degree determining can be performed on the finger before non-invasive blood glucose detection, and most stable spectral detection is performed on the finger when all interference factors are minimized.

traducir

ANALYTE MONITORING SYSTEM AND METHODS OF USE

NºPublicación: US2023007916A1 12/01/2023

Solicitante:

ABBOTT DIABETES CARE INC [US]

US_2018364215_A1

Resumen de: US2023007916A1

The present disclosure provides methods of processing data provided by a transcutaneous or subcutaneous analyte sensor utilizing different algorithms to strike a balance between signal responsiveness accompanied by signal noise and the introduction of error associated with that noise. The methods utilize the strengths of a lag correction algorithm and a smoothing algorithm to optimize the quality and value of the resulting data (glucose concentrations and the rates of change in glucose concentrations) to a continuous glucose monitoring system. Also provided are systems and kits.

traducir

INTEGRATED DISEASE MANAGEMENT SYSTEM

NºPublicación: US2023008055A1 12/01/2023

Solicitante:

EMBECTA CORP [US]

US_2021241905_A1

Resumen de: US2023008055A1

An integrated disease management system provides patients with simple, quick, and readily available counseling regarding a healthy diabetic lifestyle. The system can include an interactive engine with predictive analytics and machine learning to provide a customized experience for a user. The system can be configured to transmit data to a remote server to perform analysis of received data (e.g., disease management data), to provide feedback to the user (e.g., customized feedback with curated content based on a user's data and interface interactions) and send all or a portion of the data and/or curated content to another user device or remote health management access point (e.g., as cloud storage) where the information can be accessed by healthcare stakeholder.

traducir

ARRANGEMENT FOR OPERATING A BIOSENSOR AND ARRANGEMENT FOR DETERMINING THE GLUCOSE CONTENT IN THE BLOOD

NºPublicación: US2023011856A1 12/01/2023

Solicitante:

EYESENSE GMBH [DE]

CN_115053120_PA

Resumen de: US2023011856A1

An arrangement for operating a biosensor emitting radiation includes an excitation light source, which generates at least one excitation radiation for the biosensor; a coupling fiber, at the entry surface of which the excitation radiation is coupled in; an optical Y-coupler, including an excitation arm, which is connected to the exit surface of the coupling fiber, a detector arm, which is connected to an optical detector, and a sensor foot, which can be connected to the biosensor. The excitation arm has a conical shape. The radiation axis of the excitation arm includes an angle in the range of 5° to 70° with the main radiation axis of the detector arm. The diameter of the excitation arm at the connecting point to the detector arm is less than two thirds the diameter of the detector arm. An arrangement for determining the glucose content blood is also provided.

traducir

LIQUID MEDICINE INJECTION DEVICE

NºPublicación: US2023011504A1 12/01/2023

Solicitante:

EOFLOW CO LTD [KR]

EP_4056211_PA

Resumen de: US2023011504A1

The present disclosure relates to a liquid medicine injection device including a patch portion to which a sensor portion configured to measure blood glucose is detachable and in which an injection portion configured to inject a liquid medicine into the body of a user is installed, and a stamping portion on which the patch portion is mounted and including a first needle connectable to the sensor portion, wherein the stamping portion transmits power to the patch portion so that the first needle and a second needle, which is connected to the injection portion, are together inserted into the skin of the user, and the sensor portion and the injection portion are installed in a single device so that the convenience of use is improved when the liquid medicine injection device is attached to the skin of the user.

traducir

SYSTEM AND METHOD FOR ADJUSTING INSULIN DELIVERY

NºPublicación: US2023009339A1 12/01/2023

Solicitante:

BIGFOOT BIOMEDICAL INC [US]

US_2020108204_A1

Resumen de: US2023009339A1

The embodiments described herein may relate to methods and systems for adjusting insulin delivery. Some methods and systems may be configured to adjust insulin delivery to personalize automated insulin delivery for a person with diabetes. Some methods and systems may be configured to adjust insulin delivery to a person with diabetes according to one or more conditions of an insulin delivery device. Some methods and systems may be configured to enable a lock-out mode where adjustment to insulin delivery to personalize automated insulin delivery is restricted.

traducir

TECHNIQUES FOR RECOMMENDING RESCUE CARBOHYDRATE INGESTION IN AUTOMATIC MEDICATION DELIVERY SYSTEMS

NºPublicación: US2023011699A1 12/01/2023

Solicitante:

INSULET CORP [US]

EP_4120282_PA

Resumen de: US2023011699A1

Provided are techniques, devices and systems that include monitoring a trend of blood glucose measurement values over a series of measurement cycles. A processor may identify a potential excursion outside a range of a target blood glucose measurement value setting of a user based on the monitored trend. In response to the identified potential excursion, an alert may be generated to the user to consume rescue carbohydrates. In addition, the disclosed techniques may include a processor that assesses the factors related to a potential impending hypoglycemic event for a user. Based on a result of the assessment of the factors, the processor may determine whether the user is approaching the potential impending hypoglycemic event for the user. In response to a determination that the user is approaching the potential impending hypoglycemic event for the user, a number of rescue carbohydrates to suggest for consumption by the user may be determined.

traducir

APPARATUS AND METHOD FOR ESTIMATING BIOLOGICAL INFORMATION

NºPublicación: US2023009905A1 12/01/2023

Solicitante:

SAMSUNG ELECTRONICS CO LTD [KR]

Resumen de: US2023009905A1

An apparatus for estimating blood glucose is provided. The apparatus for estimating blood glucose may include a spectrometer configured to measure a spectrum from an object, and a processor configured to monitor a change in a contact state between the object and the spectrometer, determine a calibration section based on the monitored change in the contact state, extract a background signal from a spectrum of the determined calibration section, and generate a personalized blood glucose estimation model based on the extracted background signal.

traducir

PERITONEAL DIALYSIS SYSTEM

Nº publicación: US2023008094A1 12/01/2023

Solicitante:

MEDTRONIC INC [US]

Resumen de: US2023008094A1

In some examples, a system includes a glucose sensor configured to generate a signal indicative of a blood glucose level of a patient, a medical device configured to deliver insulin to the patient, a peritoneal dialysis (PD) device, and control circuitry. The control circuitry is configured to control the PD device to deliver PD therapy to a patient during a PD cycle, determine a blood glucose level of the patient during the PD cycle based on a signal from the glucose sensor, determine that the blood glucose level is greater than or equal to a predetermined blood glucose level threshold, and control the medical device to deliver insulin to the patient in response to determining the blood glucose level is greater than or equal to the predetermined blood glucose level threshold.

traducir

Página1 de 3 nextPage por página

punteroimgVolver